History of Pregnancy Complications Associated With Increased Ischemic Stroke Risk
By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 7, 2025 -- Women with a history of pregnancy complications may have an increased risk for ischemic stroke at a young age (younger than 50 years), according to a study published online Aug. 6 in Neurology.
Esmée Verburgt, from the Radboud Institute of Medical Innovation in the Netherlands, and colleagues conducted a case-cohort study to quantify the association between a spectrum of pregnancy complications and ischemic stroke in young women (younger than 50 years). The study included 358 women aged 18 to 49 years with first-ever imaging-proven ischemic stroke and 714 women frequency-matched on age at their most recent pregnancy and gravidity.
The researchers found that compared with women without ischemic stroke (median maternal age, 29 years), women with an ischemic stroke at a young age (median maternal age, 28 years) were more likely to have a history of hypertensive disorders of pregnancy (HDP), small for gestational age (SGA), preterm birth, gestational diabetes, stillbirth, and miscarriage. The likelihood of having a history of HDP, SGA, and preterm birth was increased for women with an ischemic stroke due to (likely) large artery disease compared with those with a cryptogenic stroke.
"While the overall risk of stroke is still very low, our study found pregnancy complications may be an early warning sign of stroke risk -- even before age 50," coauthor Frank-Erik De Leeuw, M.D., Ph.D., from Radboud University, said in a statement. "Knowing this history could help doctors identify those who may benefit from early prevention and cardiovascular care."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-08 06:00
Read more

- Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
- 2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
- Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill MK-8527
- Sugar, Sweeteners Might Trigger Early Puberty In Some Kids
- Johnson & Johnson Seeks First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
- AI Correctly Localized Almost One-Third of Interval Cancers on Screening Digital Breast Tomosynthesis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions